ARMCX1 and myelodysplastic syndrome: Regarding tissue development and differentiation, it has been reported that the absence of ARMCX1 enhances the regeneration of hematopoietic stem cells (Holmfeldt et al., 2016) and may thus regulate leukemia and MDS (Calvi and Link, 2015; Swart et al., 2017).